Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
NCT05389787

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

Led by Northwell Health · Updated on 2025-09-25

40

Participants Needed

1

Research Sites

262 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a single-site, sham-controlled, randomized trial in a total of 40 subjects between ages 18 and 60 years with schizophrenia. This study will investigate the effects of 4-week rTMS treatment on brain and cognitive functions in patients. Subjects will be randomized to one of the following arms: Arm 1: Standard of Care (SOC) and active rTMS Arm 2: Standard of Care (SOC) and sham rTMS Each participant will receive rTMS five days per week, for four consecutive weeks. Functional magnetic resonance imaging (fMRI) scans, clinical assessments, and cognitive tests will be performed at baseline, end of the 2nd week, and end of the 4th week.

CONDITIONS

Official Title

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female subjects 18 to 60 years of age
  • DSM-V diagnosis of schizophrenia spectrum disorders
  • Competent to provide informed consent
Not Eligible

You will not qualify if you...

  • Lifetime DSM-V diagnosis of an Axis-I disorder other than schizophrenia spectrum disorders
  • Lifetime diagnosis of ataxia or other cerebellar disorders
  • Lifetime diagnosis of mental retardation, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, or other neurodegenerative disorders
  • Any active general medical condition or CNS disease which can affect cognition or response to treatment
  • Substance dependence or abuse in the past six months
  • Seizure history
  • TMS within three months or ECT within six months
  • Pregnancy as indicated by self-report
  • MRI contraindications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zucker Hillside Hospital

New York, New York, United States, 11004

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here